Track topics on Twitter Track topics that are important to you
Medical Research Council20 Park Crescent
Phone: 00 44 (0) 020 7670 5274
Fax: 00 44 (0) 020 7670 5124
Cordis and Medinol have entered into an agreement in which Cordis will exclusively distribute Medinol's coronary stents in th -More-
Ectopia cordis occurs when the heart of a fetus develops outside of the chest. Learn about causes and treatment of this cogenital condition.
The FDA has granted Cordis and Medinol approval for the Elunir drug-eluting stent for use in treating blocked or narrowing c -More-
A Boca Raton law firm has brought multiple lawsuits in Florida against Miami Lakes-based medical device manufacturer Cordis Corp .-the latest in a rising wave of litigation alleging faulty vascular fi...
Body: A baby born Nov. 22 in Leicester, England, has a chance to beat the odds and survive after a rare congenital condition caused her to be delivered a month early with her heart beating outsi...
New ScientistWe need to start taking vaping seriously as a way to save livesNew ScientistIt's an unprecedented turnaround. E-cigarettes, once painted as a new and sinister health risk, are now being p...
Florida case puts new pressure on manufacturer of anti-clotting devices Osborne & Associates Law Firm, P.A., has filed suit in Palm Beach Circuit Court, alleging a ...
SummaryCordis Corporation Cordis, a subsidiary of a Cardinal Health Inc., develops and manufactures interventional vascular products in the area of cardiology as well as for use in endovascular surger...
The objective of this study is to assess the safety and effectiveness of the Cordis Bilateral AAA device and its Delivery System compared to open surgical repair for the treatment of Abdom...
To evaluate the safety and feasibility of the Cordis Neurovascular Self-Expanding Stent System to facilitate endovascular coil embolization of wide neck saccular intracranial aneurysms. ...
This study will look at the performance of the Cordis S.M.A.R.T.™ CONTROL ™ Nitinol Stent System for the treatment of TASC C & D superficial femoral artery long lesions (up to 22 cm) i...
The primary objective of this study is to compare the safety and effectiveness of the Cordis Nitinol Carotid Stent and Delivery Systems (5.5 F and 7 F) with the ANGIOGUARD XP distal prote...
Feasibility study to assess safety of treating patients with self expanding stent in intracranial arteries.
For more than 50 years, Cordis Corporation, a Johnson & Johnson company, has been a worldwide leader in the development and manufacture of interventional vascular technology. Thro...
Flashpoint Medica, a member of the Omnicom Group (NYSE: OMC), is a full-service professional agency focused on defining a brand's flashpoints by bringing unexpected solutions to ignite a brand's g...
We have published hundreds of Cordis news stories on BioPortfolio along with dozens of Cordis Clinical Trials and PubMed Articles about Cordis for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Cordis Companies in our database. You can also find out about relevant Cordis Drugs and Medications on this site too.